Global and India Prenatal Genetic Screening Test Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Software
Publisher : MRA | Format : PDF
Global and India Prenatal Genetic Screening Test Market Report & Forecast 2024-2034
Market Analysis and InsightsGlobal and India Prenatal Genetic Screening Test Market
This report focuses on global and India Prenatal Genetic Screening Test market, also covers the segmentation data of other regions in regional level and county level.
The global Prenatal Genetic Screening Test revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In India the Prenatal Genetic Screening Test revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Prenatal Genetic Screening Test include bioMérieux S.A., Biocartis Bioscience, GeneSTAT Molecular Diagnostics, Meridian Bioscience, Quidel Corporation, F. Hoffman-La Roche, Danaher, AccuBioTech and Abbott, etc. The global five biggest players hold a share of % in 2023.
Global Prenatal Genetic Screening Test Scope and Market Size
Prenatal Genetic Screening Test market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Prenatal Genetic Screening Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For India market, this report focuses on the Prenatal Genetic Screening Test market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in India.
bioMérieux S.A.
Biocartis Bioscience
GeneSTAT Molecular Diagnostics
Meridian Bioscience
Quidel Corporation
F. Hoffman-La Roche
Danaher
AccuBioTech
Abbott
DiaSorin S.p.A
Siemens Healthineers AG
Terumo Corporation
Grifols, S.A
BD
Chembio Diagnostics
EKF Diagnostics
Trinity Biotech
Instrumentation Laboratory
Nova Biomedical
PTS Diagnostics
Sekisui Diagnostics
Thermo Fisher Scientific
Segment by Type
Carrier Screening
Sequential Screening
Maternal Serum Quad Screening
Hospitals
Clinics
Diagnostic Centers
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Prenatal Genetic Screening Test definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Prenatal Genetic Screening Test companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Prenatal Genetic Screening Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prenatal Genetic Screening Test revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
This report focuses on global and India Prenatal Genetic Screening Test market, also covers the segmentation data of other regions in regional level and county level.
The global Prenatal Genetic Screening Test revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In India the Prenatal Genetic Screening Test revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Prenatal Genetic Screening Test include bioMérieux S.A., Biocartis Bioscience, GeneSTAT Molecular Diagnostics, Meridian Bioscience, Quidel Corporation, F. Hoffman-La Roche, Danaher, AccuBioTech and Abbott, etc. The global five biggest players hold a share of % in 2023.
Global Prenatal Genetic Screening Test Scope and Market Size
Prenatal Genetic Screening Test market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Prenatal Genetic Screening Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For India market, this report focuses on the Prenatal Genetic Screening Test market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in India.
By Company
bioMérieux S.A.
Biocartis Bioscience
GeneSTAT Molecular Diagnostics
Meridian Bioscience
Quidel Corporation
F. Hoffman-La Roche
Danaher
AccuBioTech
Abbott
DiaSorin S.p.A
Siemens Healthineers AG
Terumo Corporation
Grifols, S.A
BD
Chembio Diagnostics
EKF Diagnostics
Trinity Biotech
Instrumentation Laboratory
Nova Biomedical
PTS Diagnostics
Sekisui Diagnostics
Thermo Fisher Scientific
Segment by Type
Carrier Screening
Sequential Screening
Maternal Serum Quad Screening
Segment by Application
Hospitals
Clinics
Diagnostic Centers
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Prenatal Genetic Screening Test definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Prenatal Genetic Screening Test companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Prenatal Genetic Screening Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prenatal Genetic Screening Test revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions